Breaking News, Trials & Filings

Trials & Filings in Brief: Oct. 11, 2013

Endocyte, Genmab and Gentium

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Phase II Genmab positive on ofatumumab . . . read more Endocyte to continue NSCLC study . . . read more Filings COMP gives positive opinion for Gentium’s Defibrotide . . . read more...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters